Status:
COMPLETED
Assessing the Presence of Casomorphins in Human Plasma After Dairy Ingestion
Lead Sponsor:
Physicians Committee for Responsible Medicine
Conditions:
Food Habits
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
This purpose of this study is to perform a pilot investigation to determine if opioid peptides such as casomorphin can be detected in human plasma after cheese ingestion.
Detailed Description
Cheese is one of the most commonly craved foods, suggesting the possibility of opiate activity, as has been demonstrated with other craved foods, particularly chocolate. Like other dairy products, che...
Eligibility Criteria
Inclusion
- Age greater than 18 years
- Male or female
- Either self-described as having a strong liking for cheese, or have been following a vegan diet for a least the previous six months.
Exclusion
- Unstable medical status
- Physical condition affecting eating behavior, digestion, or intestinal absorption
- Dairy allergy or lactose intolerance
- Pregnancy
- History of severe mental illness
- Smoking during the past six months
- Alcohol consumption of more than two drinks per day
- History of substance abuse or dependency followed by any current use
- Inordinate fear of blood draws
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00360919
Start Date
September 1 2006
End Date
December 1 2010
Last Update
August 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Physicians Committee for Responsible Medicine
Washington D.C., District of Columbia, United States, 20016-4131